Business
Oxford-AstraZeneca vaccine is cheaper than Pfizer’s and Moderna’s and doesn’t require supercold temperature – The Conversation US
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the…
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 and it has several advantages over those of its competitors, Pfizer and Moderna.
On Monday, AstraZeneca released interim analysis of its phase 3 trial data of 23,000 volunteers from the U.K. and Brazil. These results show that the test vaccine is between 70% and 90% effective in stopping COVID-19, depending on the vaccine doses administered. Although less effective than…
-
Business22 hours agoprofit up 7%, guidance strong
-
Noosa News14 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News19 hours agoItalian Film Festival, Brisbane: All the Details
-
Noosa News15 hours agoKatter and pregnant wife crash-land plane in outback Qld